Genomic Health Inc

GHDX

Sector
Healthcare

Industry
Medical Laboratories & Research




Buy / Sell (dollars)

1 Month

14% 14% Complete (success)
86% 86% Complete (danger)
$1.974M
avg. $1.974M
$12.109M
avg. $12.109M

Buy/Sell Ratio

0.163

Transactions

25

Filers

5

3 Month

20.6% 20.6% Complete (success)
79.4% 79.4% Complete (danger)
$5.467M
avg. $1.822M
$21.025M
avg. $7.008M

Buy/Sell Ratio

0.26

Transactions

86

Filers

12

12 Month

7.3% 7.3% Complete (success)
92.7% 92.7% Complete (danger)
$18.723M
avg. $1.560M
$237.687M
avg. $19.807M

Buy/Sell Ratio

0.079

Transactions

670

Filers

16

24 Month

9.2% 9.2% Complete (success)
90.8% 90.8% Complete (danger)
$25.766M
avg. $1.074M
$254.740M
avg. $10.614M

Buy/Sell Ratio

0.101

Transactions

834

Filers

17

Recent Filings - SEC Form 4


CFO Buys & Sells

The following shows events open market buys and sells made by CFOs. The CFO is likely to be the best person within a company to watch for insider signals.
On the right you can see the maximum upside and downside produced in the 7 months after the filing was made and how long it took to arrive.
These values are updated daily.

CFO data is restricted to data over 5 years old.
You need a free account to see up-to-date data.
Log in to get free access to this feature and more.



Filers